PIQ proteomics international laboratories ltd

Ann: Director appointments, page-10

  1. 6,434 Posts.
    lightbulb Created with Sketch. 5274

    Hi Sisu & All,

    Just in relation to the discussion on CSL recently, & never saying never - CSL are looking to acquire Vifor Pharma, which is a global company based in Switzerland that specialises in cardio-renal products.

    If you remember back always, Janssen have a deal with Vifor to market Invokana (Canafliglozin) in the USA following the approval for DKD/CKD indication from the FDA. Obviously this is the drug that was trialled in the CREDENCE & CANVAS studies, which is the collaboration study between PIQ & Janssen.

    https://www.copyright link/companies/healthcare-and-fitness/csl-in-talks-to-buy-10b-swiss-based-vifor-pharma-group-20211202-p59ech?utm_medium=social&utm_campaign=nc&utm_source=Twitter#Echobox=1638430529

    So yes it does look like CSL are very interested in increasing their kidney disease assets.





    Last edited by Owl vs Fox: 02/12/21
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
38.0¢
Change
0.010(2.70%)
Mkt cap ! $62.19M
Open High Low Value Volume
37.0¢ 38.0¢ 36.0¢ $53.71K 143.5K

Buyers (Bids)

No. Vol. Price($)
1 491 38.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.5¢ 39195 2
View Market Depth
Last trade - 15.55pm 07/08/2025 (20 minute delay) ?
PIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.